NDC 0024-5824

Jevtana

Cabazitaxel

Jevtana is a Kit in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is .

Product ID0024-5824_30e263c2-3a06-4481-af0a-78a2a8156611
NDC0024-5824
Product TypeHuman Prescription Drug
Proprietary NameJevtana
Generic NameCabazitaxel
Dosage FormKit
Marketing Start Date2010-06-17
Marketing CategoryNDA / NDA
Application NumberNDA201023
Labeler NameSanofi-Aventis U.S. LLC
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0024-5824-11

1 KIT in 1 CARTON (0024-5824-11) * 5.7 mL in 1 VIAL, GLASS (0024-5823-15) * 5.7 mL in 1 VIAL, GLASS (0024-5822-01)
Marketing Start Date2010-06-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0024-5824-11 [00024582411]

Jevtana KIT
Marketing CategoryNDA
Application NumberNDA201023
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-06-17

Drug Details

OpenFDA Data

SPL SET ID:de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 1376084
  • 1001433

  • Trademark Results [Jevtana]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    JEVTANA
    JEVTANA
    78779621 3790268 Dead/Cancelled
    SANOFI-AVENTIS
    2005-12-22
    JEVTANA
    JEVTANA
    78532860 3032226 Live/Registered
    SANOFI
    2004-12-15
    JEVTANA
    JEVTANA
    77925080 4148244 Dead/Cancelled
    sanofi-aventis
    2010-02-01
    JEVTANA
    JEVTANA
    77804650 3874581 Live/Registered
    SANOFI
    2009-08-14

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.